Dr. Bryan Walsh
This insightful webinar covers some important markers, like why c-peptide is better than insulin, glycomark, why glycemic variability is worse than chronically elevated glucose, and why if you’re only running glucose and A1C you could be missing something huge. Dr. Walsh will cover fatty liver and why it is so grossly missed today by most practitioners and why it is so important to determine. This webinar will raise the concept of reimagining glucose and how practitioners may be going about this wrong – perhaps the goal shouldn’t be trying to dispose of glucose with supplements, but rather make cells healthier so they accept glucose better.
